首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >In vivo and in vitro evaluation of highly specific thiolate carrier group copper(II) and zinc(II) complexes on Ehrlich ascites carcinoma tumor model.
【24h】

In vivo and in vitro evaluation of highly specific thiolate carrier group copper(II) and zinc(II) complexes on Ehrlich ascites carcinoma tumor model.

机译:在Ehrlich腹水癌肿瘤模型中体内和对高度特异性硫醇载体载体铜(II)和锌(II)复合物的体内评价。

获取原文
获取原文并翻译 | 示例
       

摘要

A new series of copper(II) and zinc(II) complexes have been designed and synthesized using a new type of Schiff bases derived from the reaction of 3-(3-phenyl-allylidene)-pentane-2,4-dione with para substituted aniline and benzene-1,2-dithiol. Their structures have been established by analytical and spectral data. The higher varepsilon and low A( ||) values together with positive reduction potentials for these copper complexes suggest that they can mimic the functional properties of naturally occurring proteins. In vivo and in vitro antitumor functions of the complexes against Ehrlich ascites carcinoma tumor model have been investigated. The minimum inhibitory concentration of the complexes has also been investigated against Mycobacterium tuberculosis strain H37Rv. These complexes exhibit significant antitumor, cytotoxic and antituberculosis activity.
机译:设计并使用新型的Schiff碱基设计和合成了一系列新的铜(II)和锌(II)配合物,所述席位基碱源于3-(3-苯基 - 烯丙烯) - 2,4-二酮与β-2,4-二酮的反应 取代的苯胺和苯-1,2-二硫醇。 它们的结构已经通过分析和光谱数据建立。 较高的疣隆和低A(||)值以及这些铜络合物的正降低电位表明它们可以模拟天然存在的蛋白质的功能性质。 在体内和体外抗肿瘤功能对EHRLICH腹水癌肿瘤模型进行了研究。 还针对结核分枝杆菌菌株H37RV研究了复合物的最小抑制浓度。 这些配合物表现出显着的抗肿瘤,细胞毒性和抗尿囊活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号